BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16435382)

  • 1. Acquired immune cytopenias post-cardiac transplantation respond to rituximab.
    Tubman VN; Smoot L; Heeney MM
    Pediatr Blood Cancer; 2007 Mar; 48(3):339-44. PubMed ID: 16435382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies in the treatment of autoimmune cytopenias.
    Robak T
    Eur J Haematol; 2004 Feb; 72(2):79-88. PubMed ID: 14962245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
    Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
    Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura in pediatric solid organ transplant recipients, report of five cases and review of the literature.
    Miloh T; Arnon R; Roman E; Hurlet A; Kerkar N; Wistinghausen B
    Pediatr Transplant; 2011 Dec; 15(8):870-8. PubMed ID: 22112003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab in the treatment of autoimmune haematological disorders.
    Garvey B
    Br J Haematol; 2008 Apr; 141(2):149-69. PubMed ID: 18318765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome.
    Erdozain JG; Ruiz-Irastorza G; Egurbide MV; Aguirre C
    Haematologica; 2004 Sep; 89(9):ECR34. PubMed ID: 15377486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.
    Rao A; Kelly M; Musselman M; Ramadas J; Wilson D; Grossman W; Shenoy S
    Pediatr Blood Cancer; 2008 Apr; 50(4):822-5. PubMed ID: 17570702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency.
    Kim JJ; Thrasher AJ; Jones AM; Davies EG; Cale CM
    Br J Haematol; 2007 Jul; 138(1):94-6. PubMed ID: 17498197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab in autoimmune pancytopenia: a case report and review of literature.
    Reale LD; Besa EC
    Ann Hematol; 2007 Dec; 86(12):913-6. PubMed ID: 17541587
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmune cytopenias associated with autoantibodies to nuclear envelope polypeptides.
    Coppo P; Clauvel JP; Bengoufa D; Fuentes V; Gouilleux-Gruart V; Courvalin JC; Lassoued K
    Am J Hematol; 2004 Nov; 77(3):241-9. PubMed ID: 15495255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.
    El-Hallak M; Binstadt BA; Leichtner AM; Bennett CM; Neufeld EJ; Fuhlbrigge RC; Zurakowski D; Sundel RP
    J Pediatr; 2007 Apr; 150(4):376-82. PubMed ID: 17382113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune cytopenias and some associated problems of immunohematology].
    Zotikov EA
    Biull Eksp Biol Med; 1996 Apr; 121(4):364-9. PubMed ID: 8829441
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia.
    De Lord C; Marsh JC; Smith JG; Singer CR; Gordon-Smith EC
    Bone Marrow Transplant; 1996 Jul; 18(1):237-9. PubMed ID: 8832026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the current use of rituximab in autoimmune diseases.
    Gürcan HM; Keskin DB; Stern JN; Nitzberg MA; Shekhani H; Ahmed AR
    Int Immunopharmacol; 2009 Jan; 9(1):10-25. PubMed ID: 19000786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
    Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of immunocorrective therapy on immunity in patients with idiopathic autoimmune cytopenias].
    Tishchenko LM
    Vrach Delo; 1991 Aug; (8):60-3. PubMed ID: 1949738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory and autoimmune complications of common variable immune deficiency.
    Knight AK; Cunningham-Rundles C
    Autoimmun Rev; 2006 Feb; 5(2):156-9. PubMed ID: 16431351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab.
    Ramanathan S; Koutts J; Hertzberg MS
    Am J Hematol; 2005 Feb; 78(2):123-6. PubMed ID: 15682420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab.
    Radhi M; Rumelhart S; Tatman D; Goldman F
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):125-7. PubMed ID: 17279011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.